2016
DOI: 10.1002/ajh.24357
|View full text |Cite
|
Sign up to set email alerts
|

Clotting factor concentrate use and occurrence of thrombotic events in patients with hemophilia: A nationwide and 15‐year cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…In addition, few studies have investigated whether CFC use contributes to the development of CVD events in the hemophilia population. In our survey of 1105 PWH collected from Taiwan’s NHIRD between 1997 and 2011, sixty-four arterial thrombotic events, including 32 with ischemic heart disease, 27 with ischemic stroke, and 7 with peripheral arterial occlusive disease, and 5 venous thrombotic events were identified [ 25 ]. Less CFC use was found in those PWH with than without CVD events.…”
Section: Reviewmentioning
confidence: 99%
“…In addition, few studies have investigated whether CFC use contributes to the development of CVD events in the hemophilia population. In our survey of 1105 PWH collected from Taiwan’s NHIRD between 1997 and 2011, sixty-four arterial thrombotic events, including 32 with ischemic heart disease, 27 with ischemic stroke, and 7 with peripheral arterial occlusive disease, and 5 venous thrombotic events were identified [ 25 ]. Less CFC use was found in those PWH with than without CVD events.…”
Section: Reviewmentioning
confidence: 99%